Following various incidents in recent years, the control mechanisms for medical devices are being tightened throughout Europe with the new EU Medical Device Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR). What is the impact of these EU regulations for Switzerland and how do you ensure compliance on your end by the time the transition period ends?
Facing a rising tide of ICO inquiries, FINMA’s ICO Guidelines provide a more transparent regulatory framework. The guidelines address the regulatory treatment of ICO structures, anti-money laundering regulation and securities law. We offer insight into the guidelines’ impact on future ICOs in Switzerland.
The life science industry moves towards implementation of Identification of Medicinal Products (IDMP). However, the storylines about IDMP and the agenda of Drug Information Association (DIA) congresses are variegated.